Interleukin-6 Inhibition with Tocilizumab for Relapsing MOG-IgG Associated Disorder

被引：0
|
作者：
Elsbernd, Paul [1 ]
Hoffmann, William [2 ]
Wingerchuk, Dean [3 ]
Carter, Jonathan [3 ]
机构：
[1] Mayo Clin, Neurol, Tempe, AZ USA
[2] Brooke Army Med Ctr, Neurol, Tempe, AZ USA
[3] Mayo Clin, Tempe, AZ USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
11
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Interleukin-6 inhibition for the treatment of IgG4 related vasculitis☆
    Batani, Veronica
    Minici, Claudia
    Sanvito, Francesca
    Venturini, Elena
    Della-Torre, Emanuel
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 118 : 149 - 151
  • [32] Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity
    Chien, Claudia
    Scheel, Michael
    Schmitz-Huebsch, Tanja
    Borisow, Nadja
    Ruprecht, Klemens
    Bellmann-Strobl, Judith
    Paul, Friedemann
    Brandt, Alexander U.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (14) : 1926 - 1936
  • [33] Subclinical visual loss may be associated with MOG-IgG associated longitudinally extensive transverse myelitis
    Pandit, L.
    Mustafa, S.
    Ayyagiri, S.
    Sudhir, A.
    D'Cunha, A.
    Malli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 129 - 130
  • [34] A CANINE FEBRILE DISORDER ASSOCIATED WITH ELEVATED INTERLEUKIN-6
    RIVAS, AL
    TINTLE, L
    KIMBALL, ES
    SCARLETT, J
    QUIMBY, FW
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (01): : 36 - 45
  • [35] Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders
    Lopez-Chiriboga, A. Sebastian
    Majed, Masoud
    Fryer, James
    Dubey, Divyanshu
    McKeon, Andrew
    Flanagan, Eoin P.
    Jitprapaikulsan, Jiraporn
    Kothapalli, Naga
    Tillema, Jan-Mendelt
    Chen, John
    Weinshenker, Brian
    Wingerchuk, Dean
    Sagen, Jessica
    Gadoth, Avi
    Lennon, Vanda A.
    Keegan, B. Mark
    Lucchinetti, Claudia
    Pittock, Sean J.
    JAMA NEUROLOGY, 2018, 75 (11) : 1355 - 1363
  • [36] Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
    Berti, Alvise
    Cavalli, Giulio
    Campochiaro, Corrado
    Guglielmi, Barbara
    Baldissera, Elena
    Cappio, Stefano
    Sabbadini, Maria Grazia
    Doglioni, Claudio
    Dagna, Lorenzo
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 48 - 54
  • [37] INTERLEUKIN-6 IN ANCA-ASSOCIATED VASCULITIS: RATIONALE FOR THE SUCCESSFUL TREATMENT WITH TOCILIZUMAB
    Berti, A.
    Cavalli, G.
    Campochiaro, C.
    Baldissera, E.
    Sabbadini, M. G.
    Doglioni, C.
    Dagna, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 294 - 294
  • [38] Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Alvarenga, Regina Maria Papais
    Araujo, Ana Carolina Ribeiro de E. Araujo
    Nascimento, Anna Christiany Brandao
    de Araujo, Nadja Emidio Correa
    Meneguette, Nathalie Stephanie
    Neri, Vanderson Carvalho
    Alvarenga, Marina Papais
    Filho, Helcio Alvarenga
    Barros, Priscilla de Oliveira
    Bento, Cleonice Alves
    Schmidt, Sergio Luis
    Vasconcelos, Claudia Cristina Ferreira
    Alvarenga, Marcos Papais
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [39] MOG-IgG Associated Brainstem Encephalitis in a Chinese Boy: Complication of Mycoplasma pneumoniae Infection
    Leung, H. T.
    Ma, K. H.
    Tsui, K. W.
    HONG KONG JOURNAL OF PAEDIATRICS, 2023, 28 (03) : 186 - 189
  • [40] Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients
    Saito, S.
    Suzuki, K.
    Yoshimoto, K.
    Kondo, Y.
    Kikuchi, J.
    Hanaoka, H.
    Kaneko, Y.
    Takeuchi, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (07) : 1451 - 1455
12345